¥320.00
2.56%
Tokyo, Sep 30, 03:17 pm JST. Closed.
ISIN
JP3423580004
Symbol
4880

Cellsource Co.,ltd. Target price 2026 - Analyst rating & recommendation

Cellsource Co.,ltd. Classifications & Recommendation

Hold
43%
Sell
57%

Cellsource Co.,ltd. Price Target

Target Price ¥897.60
Price ¥316.00
Potential
Number of Estimates 3
3 Analysts have issued a price target Cellsource Co.,ltd. 2027 . The average Cellsource Co.,ltd. target price is ¥897.60. This is higher than the current stock price. The highest price target is
¥924.00 192.41%
register free of charge
, the lowest is
¥888.80 181.27%
register free of charge
.
A rating was issued by 7 analysts: 0 Analysts recommend Cellsource Co.,ltd. to buy, 3 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cellsource Co.,ltd. stock has an average upside potential 2027 of . Most analysts recommend the Cellsource Co.,ltd. stock at Sale.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Oct '25 2026
Estimates
Revenue Billion ¥ 3.71 3.64
14.78% 2.03%
EBITDA Margin 9.83% 6.94%
132.57% 29.43%
Net Margin 0.29% 1.65%
94.74% 474.48%

2 Analysts have issued a sales forecast Cellsource Co.,ltd. 2026 . The average Cellsource Co.,ltd. sales estimate is

¥3.6b
unlock
. This is
0.83% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
¥3.8b 3.09%
unlock
, the lowest is
¥3.5b 3.78%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 ¥3.7b 14.78%
2026
¥3.6b 2.03%
unlock
2027
¥3.8b 5.56%
unlock
2028
¥4.1b 7.89%
unlock

2 Analysts have issued an Cellsource Co.,ltd. EBITDA forecast 2026. The average Cellsource Co.,ltd. EBITDA estimate is

¥253m
unlock
. This is
45.47% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
¥263m 43.31%
unlock
, the lowest is
¥245m 47.09%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 ¥365m 98.20%
2026
¥253m 30.82%
unlock
2027
¥333m 32.00%
unlock
2028
¥424m 27.27%
unlock

EBITDA Margin

2025 9.83% 132.57%
2026
6.94% 29.43%
unlock
2027
8.68% 25.07%
unlock
2028
10.24% 17.97%
unlock

2 Cellsource Co.,ltd. Analysts have issued a net profit forecast 2026. The average Cellsource Co.,ltd. net profit estimate is

¥60.2m
unlock
. This is
14.90% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
¥62.5m 11.53%
unlock
, the lowest is
¥58.4m 17.43%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 ¥10.7m 95.52%
2026
¥60.2m 464.26%
unlock
2027
¥110m 83.33%
unlock
2028
¥192m 74.54%
unlock

Net Margin

2025 0.29% 94.74%
2026
1.65% 474.48%
unlock
2027
2.87% 73.94%
unlock
2028
4.65% 62.02%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Oct '25 2026
Estimates
Earnings Per Share ¥ 0.54 3.03
95.48% 461.11%
P/E 102.97
EV/Sales 0.43

2 Analysts have issued a Cellsource Co.,ltd. forecast for earnings per share. The average Cellsource Co.,ltd. EPS is

¥3.03
unlock
. This is
14.65% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
¥3.15 11.27%
unlock
, the lowest is
¥2.94 17.18%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 ¥0.54 95.48%
2026
¥3.03 461.11%
unlock
2027
¥5.56 83.50%
unlock
2028
¥9.70 74.46%
unlock

P/E ratio

Current 87.89 137.80%
2026
102.97 17.16%
unlock
2027
56.17 45.45%
unlock
2028
32.18 42.71%
unlock

Based on analysts' sales estimates for 2026, the Cellsource Co.,ltd. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.43 76.63%
2026
0.43 0.14%
unlock
2027
0.41 5.25%
unlock
2028
0.38 7.33%
unlock

P/S ratio

Current 1.73 42.15%
2026
1.75 0.84%
unlock
2027
1.66 5.27%
unlock
2028
1.53 7.32%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today